CONMED CNMD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $54.85M-53.8% | $47.06M-64.5% | $64.07M-51.4% | $110.2M+11.8% | $118.75M+44.2% | ||
| $17.08M+1.7% | $17.14M+3.2% | $17.28M+5.0% | $17.1M+5.6% | $16.79M+3.7% | ||
| $19.96M-39.8% | $28.32M+10.8% | $29.57M+17.1% | $31.11M+22.9% | $33.18M+34.0% | ||
| $7.72M+0.5% | $3.52M-71.1% | $9.29M+28.7% | $8.12M+84.0% | $7.68M+107% | ||
| $5.48M-4.5% | $5.65M-0.9% | $5.55M-3.6% | $5.72M-2.4% | $5.74M-3.7% | ||
| $2.74M+115% | $2.36M+45.8% | -$7.91M-358% | -$9.52M-180% | -$18.27M-167% | ||
| —— | —— | $22.44M+43.4% | $38.86M+1,121% | $34.06M+383% | ||
| —— | —— | —— | —— | -$4.97M-120% | ||
| $1.94M— | $14.91M— | —— | —— | —— | ||
| $24.95M+98.8% | $13.16M-5.4% | $16.55M+60.8% | $16.2M-8.3% | $12.55M-27.8% | ||
| -$6.61M-204% | $6.19M+246% | -$5.49M-7.2% | -$5.57M— | -$2.18M— | ||
| —— | -$558K-189% | -$466.75K+58.5% | -$375.5K+81.7% | -$284.25K+90.5% | ||
| $19.71M+162% | $22.95M+154% | $3.5M+107% | -$24.89M-16.1% | -$31.76M-137% | ||
| $142.63M-20.5% | $170.69M+2.2% | $167.69M-6.9% | $165.21M-5.6% | $179.38M+13.3% | ||
| $18.92M+27.6% | $19.81M+51.4% | $18.74M+34.8% | $16.97M+6.9% | $14.83M-11.8% | ||
| —— | —— | —— | —— | -$850K-213% | ||
| -$13.92M+0.4% | -$20.96M-60.2% | -$17.89M-28.7% | -$16.12M-1.5% | -$13.98M+21.5% | ||
| $18.57M-24.8% | $24.75M+0.4% | $24.73M+0.4% | $24.71M+0.4% | $24.68M+0.5% | ||
| —— | —— | —— | —— | —— | ||
| $709.43M+7.0% | $695.43M-7.4% | $658.43M-15.7% | $634.43M-22.5% | $663M-14.2% | ||
| $85.23M+484% | $99.82M— | $79.82M— | $54.82M— | $14.59M— | ||
| $1.46M-36.5% | $170K-94.0% | $371K-90.4% | $2.21M-21.2% | $2.3M-83.0% | ||
| -$129.98M+20.0% | -$135.82M+10.1% | -$149.52M+5.8% | -$144.83M+7.8% | -$162.38M-22.3% | ||
| $812K— | $2.45M— | $175K— | —— | —— | ||
| $1.1M— | $17.91M— | —— | —— | —— | ||
| —— | $25.42M-22.2% | $27.23M-17.3% | $29.04M-12.5% | $30.84M-7.7% | ||
| $5.48M-4.5% | $5.65M-0.9% | $5.55M-3.6% | $5.72M-2.4% | $5.74M-3.7% | ||
| $19.71M+162% | $22.95M+154% | $3.5M+107% | -$24.89M-16.1% | -$31.76M-137% | ||
| $17.08M+1.7% | $17.14M+3.2% | $17.28M+5.0% | $17.1M+5.6% | $16.79M+3.7% | ||
| —— | —— | —— | —— | —— | ||
| $1.94M— | $14.91M— | —— | —— | —— | ||
| $24.95M+98.8% | $13.16M-5.4% | $16.55M+60.8% | $16.2M-8.3% | $12.55M-27.8% | ||
| $57.78M+4.5% | $57.14M+3.4% | $56.16M+1.4% | $55.71M+0.3% | $55.28M-0.9% | ||
| —— | —— | —— | —— | -$850K-213% | ||
| —— | —— | —— | —— | —— | ||
| $37.96M+2.3% | $33.76M-40.6% | $31.37M-49.4% | $31.54M-40.8% | $37.12M-9.0% | ||
| $1.46M-36.5% | $170K-94.0% | $371K-90.4% | $2.21M-21.2% | $2.3M-83.0% | ||
| $85.23M+484% | $99.82M— | $79.82M+299% | $54.82M+174% | $14.59M-27.1% | ||
| $123.71M-24.8% | $150.88M-2.0% | $148.96M-10.3% | $148.24M-6.8% | $164.55M+16.3% | ||
| $123.71M-24.8% | $150.88M-2.0% | $148.96M-10.3% | $148.24M-6.8% | $164.55M+16.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CONMED generate?
- CONMED (CNMD) generated $142.6M in operating cash flow over the trailing twelve months.
- What is CONMED's free cash flow?
- After $18.9M of capital expenditures, CONMED's free cash flow was $123.7M over the trailing twelve months, down 24.8% year over year.
- Where does CONMED's cash flow data come from?
- Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
